• 대한한의학회지
• /
• 제31권3호
• /
• pp.34-46
• /
• 2010

Objective: This experimental study was performed to examine if Hang-Am-Dan non-boiled water extracts (HAD-N) induce apoptosis in human lung carcinoma NCI-H460 cells in vitro and inhibits the growth of NCI-H460 cell-transplanted solid tumor in vivo. Materials and Methods: We cultured NCI-H460 cell lines and xenografted them to nude mice. The mice were divided into 3 groups, NCI-H460 cell alone, NCI-H460 + 90 mg/kg HAD-N treated group, and NCI-H460 + 180 mg/kg HAD-N treated group, with seven mice per group. HAD-N was orally administrated every day for four weeks. We checked their body weight and tumor weight and volumes two times a week and their absolute organ weight and biochemical blood analysis at the final day by sacrificing them. We also calculated their tumor inhibition rate (IR), mean survival time and percent increase in life span (% ILS). Results: In this study, we observed that all of the HAD-N treated mice got smaller tumors. The more doses of HAD-N used, the less IR showed at the 8th day after starting this experiment. Tumor weight and volume of HAD-N treatment groups also decreased. Mean survival time and percent increase in life span (% ILS) in the high-dose HAD-N treatment groups were higher than those of other groups. The test substances in the blood level UN results showed reduction in the significance in both HAD-N 90 mg/kg and HAD-N 180 mg/kg (p<0.01). The blood level phosphatase results in HAD-N 90 mg/kg group compared to NCI-H460 cell alone group showed a reduction in significance (p<0.05). AST levels HAD-N 180 mg/kg group compared to NCI-H460 cell alone group significance as well (p<0.05). Conclusion: We suggest that the results of the in vivo study showed that HAD-N may have potential as a growth inhibitor of tumor-induced NCI-H460 of nude mice in spite of the shortcomings of this study. More studies to overcome those shortcomings and to find out significant antitumor mechanism will be needed.

• Journal of Pharmaceutical Investigation
• /
• 제34권3호
• /
• pp.209-214
• /
• 2004

A bioequivalence study of $Roxithrin^{TM}$ tablet (Kukje Pharma. Ind. Co., Ltd.) to $Rulid^{TM}$ tablet (Han Dok Pharma. Ind. Co., Ltd.) was conducted according to the guidelines of Korea Food and Drug Administration (KFDA). Twenty four healthy male Korean volunteers received each medicine at the roxithromycin dose of 300 mg in a $2{\times}2$ crossover study. There was a one-week wash-out period between the doses. Plasma concentrations of roxithromycin were monitored by a high-performance liquid chromatography for over a period of 36 hours after drug administration. $AUC_t$ (the area under the plasma concentration-time curve from time zero to 36 hr) was calculated by the linear trapezoidal rule method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were compiled from the plasma concentration-time data. Analysis of variance was carried out using logarithmically transformed $AUC_t$ and $C_{max}$. No significant sequence effect was found for all of the bioavailability parameters indicating that the cross-over design was properly performed. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{max}$ ratio for $Roxithrin^{TM}/Rulid^{TM}$ were 1.00 - 1.13 and 0.98 - 1.10, respectively. These values were within the acceptable bioequivalence intervals of 0.80 - 1.25. Thus, our study demonstrated the bioequivalence of $Roxithrin^{TM}$ and $Rulid^{TM}$ with respect to the rate and extent of absorption.

• Journal of Pharmaceutical Investigation
• /
• 제38권6호
• /
• pp.421-427
• /
• 2008

The purpose of the present study was to evaluate the bioequivalence of two etodolac capsules, Kuhnillodin capsule (Kuhnil. Co., Ltd., Seoul, Korea) as reference drug and Etodin capsule (Myungmun Pharm. Co., Ltd., Seoul, Korea) as test drug, according to the guidelines of Korea Food and Drug Administration (KFDA). Twenty-three healthy male Korean volunteers received one capsule at the dose of 200 mg etodolac in a $2{\times}2$ crossover study. There was a one-week washout period between the doses. Plasma concentrations of etodolac were monitored by a high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) for over a period of 24 hr after the administration. $AUC_{0-24\;hr}$ was calculated by the linear trapezoidal rule method. $C_{max}$ and $T_{max}$ were compiled from the plasma concentration-time data. Analysis of variance (ANOVA) was carried out using logarithmically transformed $AUC_{0-24\;hr}$ and $C_{max}$. The 90% confidence intervals of the $AUC_{0-24\;hr}$ ratio and the $C_{max}$ ratio for Etodin/Kuhnillodin were $\log\;0.97{\sim}\log\;1.08$ and $\log\;0.89{\sim}\log\;1.19$, respectively. These values were within the acceptable bioequivalence intervals of $\log\;0.80{\sim}\log\;1.25$. Thus, our study demonstrated that Etodin was bioeqiovalent to Kuhnillodin preparation when the rate and extent of absorption between two preparations were compared.

• 대한환경공학회지
• /
• 제28권7호
• /
• pp.697-703
• /
• 2006

물 재이용 목적으로 설계한 pilot scale의 하수 처리공정에서 배출되는 방류수 중 내분비계 장애물질을 GC/MS로 분석하였고, 처리 공정별로 제거율을 비교하였다. 각 처리 공정별 방류수에서 nonylphenol이 주로 검출되었고, 평균 $0.36{\sim}0.94$ ${\mu}g/L$으로 높게 검출되었으나, E2와 EE2는 처리수에서 정량 이하로 검출되었다. 내분비계 장애물질은 처리 공정별로 $50{\sim}100%$의 제거율을 보여주었다. E-screen assay에 의해 얻어진 양-반응 곡선에서 E2의 EC50값은 $9.0{\times}10^{-3}$ M로 bisphenol A와 p-octylphenol의 EC50값인 $2.736{\times}10^{-5}$ M, $9.760{\times}10^{-6}$ M에 비해 매우 높았다. 이는 알킬페놀류가 E2에 대한 상대적인 에스트로겐 활성도가 매우 낮음을 보여주었다. 환경 호르몬 농도와 이 물질의 상대적인 에스트로겐 활성도에 근거하여 계산된 에스트로겐 활성도(ng-EEQ/L)는 E-screen assay에 의해 실측한 총 에스트로겐 활성도(ng-EEQ/L)에 비해 평균 2배의 높은 활성도를 보여 주었다. 각 처리 공정별 방류수의 에스트로겐 활성도는 1 ng-EEQ/L 이하의 매우 낮은 활성도를 보여주었다.

• Tuberculosis and Respiratory Diseases
• /
• 제70권1호
• /
• pp.28-35
• /
• 2011

Background: The aim of the study was to describe the characteristics, treatments, and outcomes of critically ill patients with pandemic Influenza A/H1N1 2009 at a major medical center in Korea. Methods: This retrospective observational study examined critically ill adult patients with pandemic Influenza A/H1N1 2009, who were admitted to the AMC between August and December 2009. Results: 27 patients with confirmed pandemic Influenza A/H1N1 2009 were admitted to the intensive care unit (ICU) at the Asan Medical Center (AMC). The median age (IQR) was 59 years (41~67), and 66.7% of the patients were older than 51 years. A total of 81.5% of the patients had 2 or more co-morbidities. The median time (IQR) from symptom onset to presentation was 2 days (1~4), and the median time from presentation to ICU admission was 0 days (0~1.5). All patients received oseltamivir (300 mg/day) and 13 patients received triple combination therapy (oseltamivir, amantadine, ribavirin). Twelve patients required mechanical ventilation on the first day of ICU admission. A total of 6 patients (22.2%) died within 28 days of admission. The patients who died had significantly higher acute physiology and chronic health evaluation (APACHE) II and sequential organ failure assessment (SOFA) scores at presentation. There were no significant differences in age, co-morbidities, or antiviral regimens between survivors and non-survivors. Conclusion: Critical illness related to pandemic Influenza A/H1N1 2009 was common in elderly patients with chronic co-morbidities. All patients were given high-dose oseltamivir or triple combination antiviral therapy. Nonetheless, patients with critical illnesses associated with pandemic Influenza A/H1N1 2009 had a death rate of 22.2%.

• Journal of Pharmaceutical Investigation
• /
• 제34권4호
• /
• pp.319-325
• /
• 2004

A bioequivalence of $Etodol^{TM}$ tablets (Yuhan corporation) and $Kuhnillodine^{TM}$ tablets (Kuhnil Pharm. Co., Ltd.) was evaluated according to the guideline of Korea Food and Drug Administration (KFDA). Single 200 mg dose of etodolac of each medicine was administered orally to 24 healthy male volunteers. This study was performed in a $2{\times}2$ crossover design. Concentrations of etodolac in human plasma were monitored by a high-performance liquid chromatography. $AUC_t$ (the area under the plasma concentration-time curve from time zero to 24 hr) was calculated by the linear trapezoidal rule method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were compiled from the plasma concentration-time data. Analysis of variance was performed using logarithmically transformed $AUC_t$ and $C_{max}$. No significant sequence effect was found for all of the bioavailability parameters. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{max}$ ratio for $Etodol^{TM}/Kuhnillodine^{TM}$ were 1.01-1.10 and 0.87-1.06, respectively. This study demonstrated a bioequivalence of $Etodol^{TM}$ and $Kuhnillodine^{TM}$ with respect to the rate and extent of absorption.

• Journal of Pharmaceutical Investigation
• /
• 제34권6호
• /
• pp.505-511
• /
• 2004

A bioequivalence study of $Bestidine^{TM}$ tablets (Choong Wae Pharma. Corp., Korea) to Dong-A $Gaster^{TM}$ (Dong-A Pharmaceutical Co., Ltd., Korea) tablets was conducted according to the guidelines of Korea Food and Drug Administration (KFDA). Twenty four healthy male Korean volunteers received each medicine at the famotidine dose of 40 mg in a $2{\times}2$ crossover study. There was a one-week wash out period between the doses. Plasma concentrations of famotidine were monitored by a high-performance liquid chromatography for over a period of 12 hours after the administration. $AUC_t$ (the area under the plasma concentration-time curve from time zero to 12 hr) was calculated by the linear trapezoidal rule method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were compiled from the plasma concentration-time data. Analysis of variance was carried out using logarithmically transformed $AUC_t$ and $C_{max}$. No significant sequence effect was found for all of the bioavailability parameters indicating that the crossover design was properly performed. The 90% confidence intervals of the $AUC_t$ ratio and the Cmax ratio for $Bestidine^{TM}/Gaster^{TM}$ were log 0.90-log 1.06 and log 0.98-log 1.20, respectively. These values were within the acceptable bioequivalence intervals of 0.80-1.25. Thus, our study demonstrated the bioequivalence of $Bestidine^{TM}$ and $Gaster^{TM}$ with respect to the rate and extent of absorption.

• 디자인학연구
• /
• 제17권3호
• /
• pp.353-362
• /
• 2004

본 연구는 경로당 실내환경 적 요소를 평가하여 개선방안을 제시하는데 목적이 있다. 이를 위해 서울지역 14개 경로당을 방문하여 노인들의 접근성$.$이동성에 주요 영향 인자인 편의요소를 체크리스트에 기초하여 평가하였고, 조명과 색채환경을 조사하였으며, 경로당 이용자 중 124명을 대상으로 색채선호도를 설문 조사하였다. 조사결과, 1. 체크리스트의 39항목에 대한 설치율은 59%였고 접근 허용치수와 같은 의무조항에 대한 이행율은 높은 것으로 나타났다. 그러나 이동과 안전에 관한 항목은 이행정도가 낮았으므로 유도레일이나 목적지까지의 블록 설치, 장애물 제거 등이 재 고려되어야 한다. 2.평균조도는 기준치 300 Lux에 근접한 289 Lux였으나, 노인들의 원활한 활동을 지원하기에는 조명의 질이 열악하였으므로 질적 향상을 위한 조명조절기구 설치, 다양한 조명원 선택, 적절한 조명부착 및 설치 방법 등 이 적용되어야한다. 3. 대부분의 시설들은 난색상, 중명도나 고명도, 저채도 경향이 짙었으며 유사조화의 내츄럴한 분위기였다. 이는 기능적이라 할 수는 없으나 배색에 따른 분위기를 제외하고는 색채선호도에 대한 설문조사 결과와 상당부분 일치하였다. 따라서 기능성 향상을 위해 대비효과를 좀 더 주고 사용자들의 선호분위기인 클래식이나 로맨틱 이미지를 주는 배색이 권장된다.

• 분석과학
• /
• 제17권4호
• /
• pp.355-362
• /
• 2004

하나로 원자로에서 조사된 최대 선출력이 121 kW/m이고, 63 at%의 평균 연소도를 갖는 $U_3Si-Al$ 원심 분무 고출력 핵연료를 EPMA를 이용하여 파단면 관찰 및 반응층에 대한 핵분열 생성물을 분석 하였다. 조사된 고출력 $U_3Si-Al$ 핵연료를 EPMA로 화학 조성을 분석하기 위해 선행조건은 방사능 허용 한도가 $3{\times}10^{10}Bq$ 이하로 제한되는 EPMA 기기에 부합 될 수 있게 시험 시편을 최소화 하기 위한 작업이다. 시험 조건에 부합될 수 있는 시편의 제조를 위해 핵연료 천공 장치를 제작하였으며, 천공 장치를 사용하여 ${\Phi}1.57{\times}2mm$의 크기를 갖는 시료를 만들었다. 천공 된 시료를 파단 시편과 연마 시편으로 제조하여 파단면의 관찰 및 반응층(Inter-reaction layer)과 산화층에 대한 EPMA 분석을 수행하였다. 두께가 $16{\mu}m$인 반응층에 대한 평균값은 $UO_2$를 표준 시편으로 calibration한 경우의 조성은 $U_{2.84}$ Si $Al_{14}$ 이였으며, 시험 시편으로 calibration한 경우의 조성은 $U_{3.24}$ Si $Al_{14.1}$ 였다. 또한 반응층에서 핵분열 생성물의 조성을 분석하였으며, 반응층에서의 금속 석출물(metallic precipitates)의 생성은 확인할 수 없었다. 시험 시편의 산화층 조성은 $Ai_2O_3$ 임을 확인했다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제29권4호
• /
• pp.500-508
• /
• 2016

This study was conducted to investigate the effects of Momordica charantia saponin (MCS) on ruminal fermentation of maize stover and abundance of selected microbial populations in vitro. Five levels of MCS supplements (0, 0.01, 0.06, 0.30, 0.60 mg/mL) were tested. The pH, $NH_3-N$, and volatile fatty acid were measured at 6, 24, 48 h of in vitro mixed incubation fluids, whilst the selected microbial populations were determined at 6 and 24 h. The high dose of MCS increased the initial fractional rate of degradation at t-value = 0 ($FRD_0$) and the fractional rate of gas production (k), but decreased the theoretical maximum of gas production ($V_F$) and the half-life ($t_{0.5}$) compared with the control. The $NH_3-N$ concentration reached the lowest concentration with 0.01 mg MCS/mL at 6 h. The MSC inclusion increased (p<0.001) the molar proportion of butyrate, isovalerate at 24 h and 48 h, and the molar proportion of acetate at 24 h, but then decreased (p<0.05) them at 48 h. The molar proportion of valerate was increased (p<0.05) at 24 h. The acetate to propionate ratio (A/P; linear, p<0.01) was increased at 24 h, but reached the least value at the level of 0.30 mg/mL MCS. The MCS inclusion decreased (p<0.05) the molar proportion of propionate at 24 h and then increased it at 48 h. The concentration of total volatile fatty acid was decreased (p<0.001) at 24 h, but reached the greatest concentration at the level of 0.01 mg/mL and the least concentration at the level of 0.60 mg/mL. The relative abundance of Ruminococcus albus was increased at 6 h and 24 h, and the relative abundance of Fibrobacter succinogenes was the lowest (p<0.05) at 0.60 mg/mL at 6 h and 24 h. The relative abundance of Butyrivibrio fibrisolvens and fungus reached the greatest value (p<0.05) at low doses of MCS inclusion and the least value (p<0.05) at 0.60 mg/mL at 24 h. The present results demonstrates that a high level of MCS quickly inhibits in vitro fermentation of maize stover, while MCS at low doses has the ability to modulate the ruminal fermentation pattern by regulating the number of functional rumen microbes including cellulolytic bacteria and fungi populations, and may have potential as a feed additive applied in the diets of ruminants.